News for Marinus Pharmaceuticals Stock (MRNS)

The Schall Law Firm Launches An Inquiry Into Allegations Against Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Connect

Accesswire • 06/29/24

The Schall Law Firm Starts Inquiry Into Accusations Against Marinus Pharmaceuticals Inc And Invites Impacted Investors To Communicate

Accesswire • 06/29/24

ROSEN, A LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 06/28/24

The Schall Law Firm Begins Investigation Into Allegations Against Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Initiate Contact

Accesswire • 06/28/24

The Schall Law Firm Commences Investigation Into Claims Against Marinus Pharmaceuticals Inc And Invites Impacted Investors To Get In Touch

Accesswire • 06/28/24

Marinus Pharmaceuticals Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm

GlobeNewsWire • 06/28/24

Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - MRNS

PRNewsWire • 06/28/24

The Schall Law Firm Initiates Examination Into Claims Against Marinus Pharmaceuticals Inc And Urges Affected Investors To Contact

Accesswire • 06/27/24

The Schall Law Firm Initiates Probes Into Accusations Against Marinus Pharmaceuticals Inc And Urges Affected Investors To Make Contact

Accesswire • 06/27/24

MARINUS PHARMACEUTICALS, INC. (NASDAQ:MRNS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc.

Accesswire • 06/27/24

The Schall Law Firm Initiates Inquiry Into Claims Against Marinus Pharmaceuticals Inc And Urges Affected Investors To Establish Communication

Accesswire • 06/26/24

The Schall Law Firm Initiates Probe Into Claims Against Marinus Pharmaceuticals Inc And Urges Affected Investors To Contact

Accesswire • 06/26/24

The Schall Law Firm Commences Scrutiny Into Accusations Against Marinus Pharmaceuticals Inc And Calls For Affected Investors To Connect

Accesswire • 06/25/24

MRNS SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marinus Pharmaceuticals, Inc. Investors Can Join the Class Action Lawsuit!

Accesswire • 06/25/24

The Schall Law Firm Begins Investigation Into Allegations Against Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Reach Out

Accesswire • 06/25/24

The Schall Law Firm Initiates Probe Into Claims Against Marinus Pharmaceuticals Inc And Urges Affected Investors To Connect

Accesswire • 06/24/24

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 06/24/24

The Schall Law Firm Starts Looking Into Claims Against Marinus Pharmaceuticals Inc And Urges Investors Who Are Affected To Begin Dialogue

Accesswire • 06/23/24

The Schall Law Firm Initiates Probe Into Claims Against Marinus Pharmaceuticals Inc And Urges Affected Investors To Establish Communication

Accesswire • 06/21/24

The Schall Law Firm Initiates Probe Into Claims Against Marinus Pharmaceuticals Inc And Invites Affected Investors To Get In Touch

Accesswire • 06/21/24

The Schall Law Firm Initiates A Probe Into Claims Against Marinus Pharmaceuticals Inc And Urges Affected Shareholders To Make Contact

Accesswire • 06/20/24

MRNS Class Action Alert: Robbins LLP Reminds MRNS Stockholders About the Marinus Pharmaceuticals, Inc. Securities Fraud Class Action

GlobeNewsWire • 06/20/24

Investigations Into Allegations Against Marinus Pharmaceuticals Inc Have Been Initiated By The Schall Law Firm And It Encourages Affected Investors To Reach Out

Accesswire • 06/20/24

The Schall Law Firm Starts Investigation Into Allegations Against Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Reach Out

Accesswire • 06/20/24

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 06/19/24